AS-IV upregulates the levels of Ki67, MMP-2, and MMP-9 by regulating the MAPK/ERK signaling pathway, which further results in the suppression of tumor cell growth, migration, and invasion abilities (Li et al., 2017). The gene discussed is MMP9; the disease is neoplasm.